Effects of interleukin-1, tumor necrosis factor -beta, and forskolin on tissue plasminogen activator activity in human osteoblastic osteosarcoma cells

Calcif Tissue Int. 1992 Feb;50(2):129-33. doi: 10.1007/BF00298789.

Abstract

The effects of interleukin-1 (IL-1), forskolin, and tumor necrosis factor beta (TNF-beta) on tissue plasminogen activator (t-PA) activity were studied in the human osteoblastic osteosarcoma cell line, G292. t-PA activity was measured in the cell media using the chromogenic substrate, S-2251. After a 24 hour incubation period, IL-1 increased t-PA in a dose-dependent manner. The effect of IL-1 at 10.0 U/ml was partially inhibited in the presence of indomethacin. Forskolin (1.0 microM) increased t-PA activity after 24 hours with the effects of combined treatment of IL-1 (1.0 U/ml, 10.0 U/ml) and forskolin being apparently additive in nature. TNF-beta (10(-8)-10(-7)M) also produced increased t-PA activity in the cell media after a 24 hour incubation period. These results suggest that the cytokines, IL-1 and TNF-beta, can increase t-PA activity in G292 cells and that there is both a cAMP-dependent as well as a cAMP-independent pathway involved in the regulation of this osteoblastic cell function.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Colforsin / pharmacology*
  • Growth Substances / pharmacology*
  • Humans
  • Indomethacin / pharmacology
  • Interleukin-1 / pharmacology
  • Lymphotoxin-alpha / pharmacology
  • Osteoblasts / drug effects
  • Osteoblasts / metabolism*
  • Osteosarcoma / metabolism*
  • Tissue Plasminogen Activator / drug effects
  • Tissue Plasminogen Activator / metabolism*
  • Tumor Cells, Cultured

Substances

  • Growth Substances
  • Interleukin-1
  • Lymphotoxin-alpha
  • Colforsin
  • Tissue Plasminogen Activator
  • Indomethacin